Innate and Adaptive Interleukin-22 Protects Mice from Inflammatory Bowel Disease

Immunity

Volumn 29, Issue 6, 2008, Pages 947-957

  Zenewicz, Lauren A ^a   Yancopoulos, George D ^b   Valenzuela, David M ^b   Murphy, Andrew J ^b   Stevens, Sean ^b   Flavell, Richard A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b REGENERON PHARMACEUTICALS INC   (United States)

Author keywords

CELLIMMUNO; MOLIMMUNO

Indexed keywords

INTERLEUKIN 22;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL SUBPOPULATION; CONTROLLED STUDY; ENTERITIS; HUMAN; HUMAN CELL; INNATE IMMUNITY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; COLITIS; COLON; CYTOKINES; DISEASE MODELS, ANIMAL; HOMEODOMAIN PROTEINS; HUMANS; IMMUNITY, ACTIVE; IMMUNITY, INNATE; INFLAMMATORY BOWEL DISEASES; INTERLEUKINS; KILLER CELLS, NATURAL; MICE; MICE, KNOCKOUT; RECOMBINANT PROTEINS; T-LYMPHOCYTE SUBSETS;

EID: 57449090428     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2008.11.003     Document Type: Article

References (48)

1. Aggarwal S., Ghilardi N., Xie M.H., de Sauvage F.J., and Gurney A.L. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278 (2003) 1910-1914
2. Andoh A., Zhang Z., Inatomi O., Fujino S., Deguchi Y., Araki Y., Tsujikawa T., Kitoh K., Kim-Mitsuyama S., Takayanagi A., et al. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology 129 (2005) 969-984
3. +-cell depleted, athymic and NK-cell depleted SCID mice. Inflamm. Res. 45 (1996) 181-191
4. Blumberg H., Conklin D., Xu W.F., Grossmann A., Brender T., Carollo S., Eagan M., Foster D., Haldeman B.A., Hammond A., et al. Interleukin 20: Discovery, receptor identification, and role in epidermal function. Cell 104 (2001) 9-19
5. Boniface K., Lecron J.C., Bernard F.X., Dagregorio G., Guillet G., Nau F., and Morel F. Keratinocytes as targets for interleukin-10-related cytokines: A putative role in the pathogenesis of psoriasis. Eur. Cytokine Netw. 16 (2005) 309-319
6. Brand S., Beigel F., Olszak T., Zitzmann K., Eichhorst S.T., Otte J.M., Diepolder H., Marquardt A., Jagla W., Popp A., et al. IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am. J. Physiol. Gastrointest. Liver Physiol. 290 (2006) G827-G838
7. Cao X., Shores E.W., Hu-Li J., Anver M.R., Kelsall B.L., Russell S.M., Drago J., Noguchi M., Grinberg A., Bloom E.T., et al. Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity 2 (1995) 223-238
8. Chung Y., Yang X., Chang S.H., Ma L., Tian Q., and Dong C. Expression and regulation of IL-22 in the IL-17-producing CD4+ T lymphocytes. Cell Res. 16 (2006) 902-907
9. Cooper H.S., Murthy S.N., Shah R.S., and Sedergran D.J. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab. Invest. 69 (1993) 238-249
10. Cua D.J., Sherlock J., Chen Y., Murphy C.A., Joyce B., Seymour B., Lucian L., To W., Kwan S., Churakova T., et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421 (2003) 744-748
11. Dieleman L.A., Ridwan B.U., Tennyson G.S., Beagley K.W., Bucy R.P., and Elson C.O. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 107 (1994) 1643-1652
12. DiSanto J.P., Muller W., Guy-Grand D., Fischer A., and Rajewsky K. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. Proc. Natl. Acad. Sci. USA 92 (1995) 377-381
13. Duerr R.H., Taylor K.D., Brant S.R., Rioux J.D., Silverberg M.S., Daly M.J., Steinhart A.H., Abraham C., Regueiro M., Griffiths A., et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314 (2006) 1461-1463
14. Dumoutier L., Leemans C., Lejeune D., Kotenko S.V., and Renauld J.C. Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. J. Immunol. 167 (2001) 3545-3549
15. Dumoutier L., Van Roost E., Colau D., and Renauld J.C. Human interleukin-10-related T cell-derived inducible factor: Molecular cloning and functional characterization as an hepatocyte-stimulating factor. Proc. Natl. Acad. Sci. USA 97 (2000) 10144-10149
16. + T cells in a transfer model of colitis. J. Immunol. 161 (1998) 3256-3261
17. Fujino S., Andoh A., Bamba S., Ogawa A., Hata K., Araki Y., Bamba T., and Fujiyama Y. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52 (2003) 65-70
18. Hayakawa Y., Huntington N.D., Nutt S.L., and Smyth M.J. Functional subsets of mouse natural killer cells. Immunol. Rev. 214 (2006) 47-55
19. Hue S., Ahern P., Buonocore S., Kullberg M.C., Cua D.J., McKenzie B.S., Powrie F., and Maloy K.J. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J. Exp. Med. 203 (2006) 2473-2483
20. Korn T., Bettelli E., Gao W., Awasthi A., Jager A., Strom T.B., Oukka M., and Kuchroo V.K. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448 (2007) 484-487
21. Kotake S., Udagawa N., Takahashi N., Matsuzaki K., Itoh K., Ishiyama S., Saito S., Inoue K., Kamatani N., Gillespie M.T., et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J. Clin. Invest. 103 (1999) 1345-1352
22. Kotenko S.V. The family of IL-10-related cytokines and their receptors: related, but to what extent?. Cytokine Growth Factor Rev. 13 (2002) 223-240
23. Kotenko S.V., Izotova L.S., Mirochnitchenko O.V., Esterova E., Dickensheets H., Donnelly R.P., and Pestka S. Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity. J. Immunol. 166 (2001) 7096-7103
24. Kullberg M.C., Jankovic D., Feng C.G., Hue S., Gorelick P.L., McKenzie B.S., Cua D.J., Powrie F., Cheever A.W., Maloy K.J., and Sher A. IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J. Exp. Med. 203 (2006) 2485-2494
25. Laan M., Cui Z.H., Hoshino H., Lotvall J., Sjostrand M., Gruenert D.C., Skoogh B.E., and Linden A. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J. Immunol. 162 (1999) 2347-2352
26. Liang S.C., Tan X.Y., Luxenberg D.P., Karim R., Dunussi-Joannopoulos K., Collins M., and Fouser L.A. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203 (2006) 2271-2279
27. Ma H.L., Liang S., Li J., Napierata L., Brown T., Benoit S., Senices M., Gill D., Dunussi-Joannopoulos K., Collins M., et al. IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J. Clin. Invest. 118 (2008) 597-607
28. Mahler M., Bristol I.J., Leiter E.H., Workman A.E., Birkenmeier E.H., Elson C.O., and Sundberg J.P. Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis. Am. J. Physiol. 274 (1998) G544-G551
29. McGeachy M.J., Bak-Jensen K.S., Chen Y., Tato C.M., Blumenschein W., McClanahan T., and Cua D.J. TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat. Immunol. 8 (2007) 1390-1397
30. Moore K.W., de Waal Malefyt R., Coffman R.L., and O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19 (2001) 683-765
31. + T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells. J. Exp. Med. 178 (1993) 237-244
32. Nurieva R., Yang X.O., Martinez G., Zhang Y., Panopoulos A.D., Ma L., Schluns K., Tian Q., Watowich S.S., Jetten A.M., and Dong C. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448 (2007) 480-483
33. Podolsky D.K. Inflammatory bowel disease. N. Engl. J. Med. 347 (2002) 417-429
34. low CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. J. Exp. Med. 179 (1994) 589-600
35. hi CD4+ T cells. Immunity 1 (1994) 553-562
36. Radaeva S., Sun R., Pan H.N., Hong F., and Gao B. Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 39 (2004) 1332-1342
37. Saubermann L.J., Beck P., De Jong Y.P., Pitman R.S., Ryan M.S., Kim H.S., Exley M., Snapper S., Balk S.P., Hagen S.J., et al. Activation of natural killer T cells by α-galactosylceramide in the presence of CD1d provides protection against colitis in mice. Gastroenterology 119 (2000) 119-128
38. + T cells in an experimental model of colitis. Eur. J. Immunol. 27 (1997) 17-25
39. Sugimoto K., Ogawa A., Mizoguchi E., Shimomura Y., Andoh A., Bhan A.K., Blumberg R.S., Xavier R.J., and Mizoguchi A. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J. Clin. Invest. 118 (2008) 534-544
40. te Velde A.A., de Kort F., Sterrenburg E., Pronk I., ten Kate F.J., Hommes D.W., and van Deventer S.J. Comparative analysis of colonic gene expression of three experimental colitis models mimicking inflammatory bowel disease. Inflamm. Bowel Dis. 13 (2007) 325-330
41. Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., and Stockinger B. TGF-β in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24 (2006) 179-189
42. Weaver C.T., Harrington L.E., Mangan P.R., Gavrieli M., and Murphy K.M. Th17: An effector CD4 T cell lineage with regulatory T cell ties. Immunity 24 (2006) 677-688
43. Wolk K., Kunz S., Asadullah K., and Sabat R. Cutting edge: immune cells as sources and targets of the IL-10 family members?. J. Immunol. 168 (2002) 5397-5402
44. Wolk K., Kunz S., Witte E., Friedrich M., Asadullah K., and Sabat R. IL-22 increases the innate immunity of tissues. Immunity 21 (2004) 241-254
45. Wolk K., Witte E., Reineke U., Witte K., Friedrich M., Sterry W., Asadullah K., Volk H.D., and Sabat R. Is there an interaction between interleukin-10 and interleukin-22?. Genes Immun. 6 (2005) 8-18
46. Zenewicz L.A., Yancopoulos G.D., Valenzuela D.M., Murphy A.J., Karow M., and Flavell R.A. Interleukin-22 but Not Interleukin-17 Provides Protection to Hepatocytes during Acute Liver Inflammation. Immunity 27 (2007) 647-659
47. Zheng Y., Danilenko D.M., Valdez P., Kasman I., Eastham-Anderson J., Wu J., and Ouyang W. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445 (2007) 648-651
48. Ziesche E., Bachmann M., Kleinert H., Pfeilschifter J., and Muhl H. The interleukin-22/STAT3 pathway potentiates expression of inducible nitric-oxide synthase in human colon carcinoma cells. J. Biol. Chem. 282 (2007) 16006-16015